Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deeb

Showing results (151-160 of 156) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 156 results.
Scientific Reports|October 28, 2022
Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levelsYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Trials|February 1, 2018
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trialYaseen M Arabi, Adel Alothman, Hanan H Balkhy, et al.
American Journal of Respiratory and Critical Care Medicine|November 22, 2017
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeYaseen M Arabi, Yasser Mandourah, Fahad Al-Hameed, et al.
Influenza and Other Respiratory Viruses|March 24, 2023
Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trialFaizah Alotaibi, Naif Khalaf Alharbi, Lindsey B Rosen, et al.
Trials|January 5, 2020
Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trialYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
The New England Journal of Medicine|October 7, 2020
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory SyndromeYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Pageof 16

Showing results (151-160 of 156) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 156 results.
Scientific Reports|October 28, 2022
Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levelsYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Trials|February 1, 2018
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trialYaseen M Arabi, Adel Alothman, Hanan H Balkhy, et al.
American Journal of Respiratory and Critical Care Medicine|November 22, 2017
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory SyndromeYaseen M Arabi, Yasser Mandourah, Fahad Al-Hameed, et al.
Influenza and Other Respiratory Viruses|March 24, 2023
Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trialFaizah Alotaibi, Naif Khalaf Alharbi, Lindsey B Rosen, et al.
Trials|January 5, 2020
Treatment of Middle East respiratory syndrome with a combination of lopinavir/ritonavir and interferon-β1b (MIRACLE trial): statistical analysis plan for a recursive two-stage group sequential randomized controlled trialYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
The New England Journal of Medicine|October 7, 2020
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory SyndromeYaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, et al.
Pageof 16